Verastem (VSTM) Stock News
$VSTM · NASDAQ · 3 stories in 30 daysBORSA has published 3 stories on Verastem (VSTM) in the past 30 days. BORSA’s news read on VSTM is leaning bullish at 53/100, unchanged over 24 hours, based on 3 company events over the past 30 days. VSTM last closed at $8.25 on Oct 12, up 3.13% over five sessions and up 12.70% over the past month. Verastem’s next earnings report is scheduled for Tuesday, Nov 3.
The wire on $VSTM
newest first · updated · direct subject stories onlyBTIG maintains $18.00 price target for Verastem
BTIG maintained its price target for Verastem at $18.00 per share.
neutral 50 · impact 20Verastem Oncology grants inducement RSUs and options to new employees
Verastem Oncology granted 380,500 RSUs to 24 new employees and options for 50,000 shares to one new employee at $7.90 exercise price. Vesting occurs over four years. The awards are inducement grants under Nasdaq Listing Rule 5635(c)(4).
neutral 50 · impact 10
